Characteristics | Training group (n = 27) | Validation group(n = 29) |
---|---|---|
Primary site | ||
 Oropharynx | 16 (59.3%) | 20 (69.0%) |
 Larynx | 2 (7.4%) | 4 (13.8%) |
 Nasopharynx and Sinonasal | 4 (14.8%) | 2 (6.9%) |
 Other sites | 5 (18.5%) | 3 (10.3%) |
Stage | ||
 I | 3 (11.1%) | 2 (6.9%) |
 II | 3 (11.1%) | 3 (10.3%) |
 III | 5 (18.5%) | 6 (20.7%) |
 IV | 16 (59.3%) | 17 (58.6%) |
 N/X | 0 (0%) | 1 (3.5%) |
Primary Tumor Surgery | ||
 Yes | 15 | 17 |
 No | 12 | 12 |